1. Home
  2. BLCO vs WLK Comparison

BLCO vs WLK Comparison

Compare BLCO & WLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

SELL

Current Price

$20.86

Market Cap

7.1B

Sector

Health Care

ML Signal

SELL

Logo Westlake Corporation

WLK

Westlake Corporation

SELL

Current Price

$62.29

Market Cap

8.1B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
BLCO
WLK
Founded
1853
1986
Country
Canada
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
8.1B
IPO Year
2022
2004

Fundamental Metrics

Financial Performance
Metric
BLCO
WLK
Price
$20.86
$62.29
Analyst Decision
Buy
Buy
Analyst Count
15
17
Target Price
$21.93
★ $77.47
AVG Volume (30 Days)
★ 977.3K
858.3K
Earning Date
10-28-2026
11-04-2026
Dividend Yield
N/A
★ 3.46%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.75
Revenue
$5,101,000,000.00
★ $11,170,000,000.00
Revenue This Year
$7.83
$3.95
Revenue Next Year
$5.90
$1.24
P/E Ratio
★ N/A
$82.20
Revenue Growth
★ 6.47
N/A
52 Week Low
$14.44
$56.33
52 Week High
$21.40
$124.23

Technical Indicators

Market Signals
Indicator
BLCO
WLK
Relative Strength Index (RSI) 67.50 43.80
Support Level $15.30 $59.66
Resistance Level $21.38 $79.22
Average True Range (ATR) 0.62 2.49
MACD 0.03 -0.33
Stochastic Oscillator 71.81 15.74

Price Performance

Historical Comparison
BLCO
WLK

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes brands like Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, and surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xiidra and Miebo that treat various eye complications.

About WLK Westlake Corporation

Westlake is a forward-integrated commodity chemicals firm based in Houston. It began as a single low-density polyethylene plant and expanded its capabilities to include ethylene, vinyl chloride monomers, and polyvinyl chloride over the next two decades. The acquisition of Axiall in 2016 made it a North American leader in chlor-alkali and PVC. Today, Westlake has two defined segments: performance and essential materials, and housing and infrastructure products. The HIP segment began operating in 2022 following a series of acquisitions in the building products space. The firm aims to maximize the value of its chemical production by integrating with the HIP segment, realizing the higher margins of finished commercial goods.

Share on Social Networks: